EMOCARE is a smartphone-based passive monitoring tool that generates a continuous, real-time measure of depression from patient voice, facial ...

SAN FRANCISCO — Luvesilocin, a novel psychedelic 5-hydroxytryptamine receptor 2A (5HT2A) agonist compound formerly known as RE104, was associated with fast and durable improvement in women with ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...

Navacaprant did not statistically significantly improve MADRS total score or SHAPS total score compared with placebo. Topline data were announced from a phase 3 trial evaluating navacaprant for the ...

Treatment-resistant depression reflects ≥2 adequate antidepressant failures in one episode and carries high cumulative burden, including prolonged episodes, repeated failures, and substantial work ...